Cambridge, England, 24 September 2020 – Exhalation Technology has appointed The Sage Group to lead the partnering program for its novel CoronaCheck™ diagnostic test for Covid-19 in exhaled breath condensate. This is a rapid (<5 minutes) test of high specificity and sensitivity for Covid-19, meeting the need for testing in a wide range of environments. Exhalation Technology (“ETL”) seeks a global strategic partner with which it can collaborate to exploit its new Covid-19 test. ETL has a strong history in development of diagnostic products based on analysis of the respiratory tract where Covid-19 is prevalent. ETL has developed a very unique and timely, IP protected test for rapid detection of
